by Jordana Choucair | Dec 9, 2021 | Opioid/Substance Use Disorders
The Substance Abuse and Mental Health Services Administration announced it will distribute $30 million in grants to providers to boost harm reduction strategies. State and local governments, community-based organizations, and primary and behavioral health...
by Jordana Choucair | Dec 7, 2021 | Opioid/Substance Use Disorders
Representative Donald Norcross and Senator Ed Markey announced legislation Monday that would expand access to opioid medication. The Opioid Treatment Access Act targets restrictions on methadone. The bill specifically would make the easing of restrictions approved...
by Jordana Choucair | Nov 24, 2021 | Opioid/Substance Use Disorders
A jury in Ohio ruled that three major pharmaceutical chains bore responsibility for the opioid epidemic in two Ohio counties. The civil case, brought in federal court against CVS, Walmart, and Walgreens, marks the first time pharmacies have been found responsible in...
by Jordana Choucair | Nov 18, 2021 | Opioid/Substance Use Disorders
More than 3,300 lawsuits have been filed against drug manufacturers, distributors, and pharmacies for their role in exacerbating the country’s opioid epidemic. Recognizing that final verdicts in these legal proceedings could take years, Senior Director Tym Rourke...
by Jordana Choucair | Nov 18, 2021 | Opioid/Substance Use Disorders
Provisional data from the CDC shows that an estimated 100,306 people in the U.S. died from a drug overdose in a 12-month period ending April 2021. It’s the first time drug overdose fatalities reached six figures in a single year, and signals that the country is...
by Jordana Choucair | Nov 16, 2021 | Opioid/Substance Use Disorders
Washington Attorney General Bob Ferguson argued in court that three large drug distributors violated the state’s public nuisance and consumer protection laws because they didn’t have tracking systems in place to prevent illegitimate sales and distribution of...
Recent Comments